Delivery Order SPE2DE21D7020-SPE2D625F64JK

Award Date 2/5/25
Potential Completion Date 2/12/25
Potential Value $4.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Marlborough, MA 01752, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, a leading manufacturer of medical devices. The contract, valued at $1,433.65, is for the delivery of various medical supplies and equipment, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters, stents, and surgical implants. The contract does...
This is a federal contract award to Boston Scientific Corp, a leading manufacturer of medical devices, by the Defense Health Agency (DHA) under the Medical Supply Chain program. The contract, valued at $3,717.20, is a delivery order for the supply of various medical products, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters, stents, and surgical implants. The contract has a fixed...
The U.S. Department of Defense's Medical Supply Chain (VPDLATSMED-A) awarded a $12,485.20 fixed-price delivery order contract to Boston Scientific Corp, a leading manufacturer of medical devices. The contract, awarded under no set-aside, has an ultimate completion date of May 15, 2024. Boston Scientific will provide a variety of medical products and services, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems,...
This federal contract award, valued at $1,161.72, was issued by the Defense Health Agency (DHA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The contract is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract and includes the provision of medical supplies and equipment, such as implantable cardioverter defibrillators, pacemakers, and various surgical implants. Boston Scientific has a significant history of supporting federal...
This is a $2,833.60 fixed-price delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency, to Boston Scientific Corp, a leading manufacturer of medical devices. The contract has an ultimate completion date of October 21, 2024 and is not set aside. Boston Scientific will provide the government with a variety of innovative, minimally invasive medical technologies and solutions, including implantable cardioverter defibrillators, pacemakers, neurostimulation...
This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The $3,385.90 fixed-price contract with economic price adjustment has a performance period through February 11, 2025. The contract is not set aside and covers the supply of medical products such as implantable cardioverter defibrillators, pacemakers, and other specialized...
This is a federal contract award to Boston Scientific Corp, a leading manufacturer of medical devices, by the Defense Health Agency (DHA) under the Medical Supply Chain program. The contract, valued at $1,470.00, is a delivery order under a larger indefinite delivery/indefinite quantity (IDIQ) contract. The contract is for the supply of various medical technologies, including implantable cardioverter defibrillators, pacemakers, and other devices used in cardiovascular, rhythm management, and...
This is a delivery order awarded to Boston Scientific Corp, a leading manufacturer of medical devices, by the Defense Health Agency (DHA). The contract, valued at $24,970.40, is for the provision of medical supplies and equipment, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, and other surgical implants. The award is not associated with a set-aside program and has an ultimate completion date of January 3, 2024....
This is a federal contract award to Boston Scientific Corp, a for-profit medical device manufacturer, by the Defense Health Agency (DHA) and Department of Veterans Affairs (VA). The contract, valued at $8,757.73, is a Delivery Order with a Fixed Price and Economic Price Adjustment pricing type. The contract has an ultimate completion date of February 10, 2025 and is not set aside. Boston Scientific, headquartered in Marlborough, Massachusetts, specializes in developing and manufacturing...
This is a federal contract award to Boston Scientific Corp, doing business as Boston Scientific, a leading manufacturer of medical devices. The contract, valued at $1,504.80, is a delivery order awarded by the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract is for the supply of medical devices, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters,...
  • SPE2DE21D7020
    Indefinite Delivery Contract
  • SPE2DE21D7020-SPE2D625F64JK
    Delivery Order

This is a federal delivery order contract awarded by the Defense Health Agency (DHA) to Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $4,454.16, is for the provision of medical supplies and equipment, including implantable cardioverter defibrillators, pacemakers, cardiac resynchronization therapy devices, neurostimulation systems, drug-coated balloons, catheters, stents, and surgical implants. The contract does not have a set-aside designation and is scheduled for completion by February 12, 2025. Boston Scientific is a critical supplier of specialized medical technologies to federal healthcare agencies such as the Department of Veterans Affairs (VA), and this award reflects the company's strategic importance in supporting the medical needs of the U.S. military and veteran populations.

Generated 5/7/25, 9:56 AM